Request for Covid-19 Impact Assessment of this Report
The United States Endoparasiticide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Endoparasiticide market, reaching US$ million by the year 2028. As for the Europe Endoparasiticide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Endoparasiticide players cover Boehringer Ingelheim, Elanco, Zoetis, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Endoparasiticide market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Ear Tags
Tablets
Injectables
Feed Additives
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Veterinary Hospitals or Clinics
Animal Farms
Home Care Settings
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Boehringer Ingelheim
Elanco
Zoetis
Merck
Virbac
Novartis AG
Ceva Sante Animlae
Bayer AG
Eli Lilly
Vetoquinol
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Endoparasiticide Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Endoparasiticide by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Endoparasiticide by Country/Region, 2017, 2022 & 2028
2.2 Endoparasiticide Segment by Type
2.2.1 Ear Tags
2.2.2 Tablets
2.2.3 Injectables
2.2.4 Feed Additives
2.3 Endoparasiticide Sales by Type
2.3.1 Global Endoparasiticide Sales Market Share by Type (2017-2022)
2.3.2 Global Endoparasiticide Revenue and Market Share by Type (2017-2022)
2.3.3 Global Endoparasiticide Sale Price by Type (2017-2022)
2.4 Endoparasiticide Segment by Application
2.4.1 Veterinary Hospitals or Clinics
2.4.2 Animal Farms
2.4.3 Home Care Settings
2.5 Endoparasiticide Sales by Application
2.5.1 Global Endoparasiticide Sale Market Share by Application (2017-2022)
2.5.2 Global Endoparasiticide Revenue and Market Share by Application (2017-2022)
2.5.3 Global Endoparasiticide Sale Price by Application (2017-2022)
3 Global Endoparasiticide by Company
3.1 Global Endoparasiticide Breakdown Data by Company
3.1.1 Global Endoparasiticide Annual Sales by Company (2020-2022)
3.1.2 Global Endoparasiticide Sales Market Share by Company (2020-2022)
3.2 Global Endoparasiticide Annual Revenue by Company (2020-2022)
3.2.1 Global Endoparasiticide Revenue by Company (2020-2022)
3.2.2 Global Endoparasiticide Revenue Market Share by Company (2020-2022)
3.3 Global Endoparasiticide Sale Price by Company
3.4 Key Manufacturers Endoparasiticide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Endoparasiticide Product Location Distribution
3.4.2 Players Endoparasiticide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Endoparasiticide by Geographic Region
4.1 World Historic Endoparasiticide Market Size by Geographic Region (2017-2022)
4.1.1 Global Endoparasiticide Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Endoparasiticide Annual Revenue by Geographic Region
4.2 World Historic Endoparasiticide Market Size by Country/Region (2017-2022)
4.2.1 Global Endoparasiticide Annual Sales by Country/Region (2017-2022)
4.2.2 Global Endoparasiticide Annual Revenue by Country/Region
4.3 Americas Endoparasiticide Sales Growth
4.4 APAC Endoparasiticide Sales Growth
4.5 Europe Endoparasiticide Sales Growth
4.6 Middle East & Africa Endoparasiticide Sales Growth
5 Americas
5.1 Americas Endoparasiticide Sales by Country
5.1.1 Americas Endoparasiticide Sales by Country (2017-2022)
5.1.2 Americas Endoparasiticide Revenue by Country (2017-2022)
5.2 Americas Endoparasiticide Sales by Type
5.3 Americas Endoparasiticide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endoparasiticide Sales by Region
6.1.1 APAC Endoparasiticide Sales by Region (2017-2022)
6.1.2 APAC Endoparasiticide Revenue by Region (2017-2022)
6.2 APAC Endoparasiticide Sales by Type
6.3 APAC Endoparasiticide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Endoparasiticide by Country
7.1.1 Europe Endoparasiticide Sales by Country (2017-2022)
7.1.2 Europe Endoparasiticide Revenue by Country (2017-2022)
7.2 Europe Endoparasiticide Sales by Type
7.3 Europe Endoparasiticide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Endoparasiticide by Country
8.1.1 Middle East & Africa Endoparasiticide Sales by Country (2017-2022)
8.1.2 Middle East & Africa Endoparasiticide Revenue by Country (2017-2022)
8.2 Middle East & Africa Endoparasiticide Sales by Type
8.3 Middle East & Africa Endoparasiticide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Endoparasiticide
10.3 Manufacturing Process Analysis of Endoparasiticide
10.4 Industry Chain Structure of Endoparasiticide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Endoparasiticide Distributors
11.3 Endoparasiticide Customer
12 World Forecast Review for Endoparasiticide by Geographic Region
12.1 Global Endoparasiticide Market Size Forecast by Region
12.1.1 Global Endoparasiticide Forecast by Region (2023-2028)
12.1.2 Global Endoparasiticide Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Endoparasiticide Forecast by Type
12.7 Global Endoparasiticide Forecast by Application
13 Key Players Analysis
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Endoparasiticide Product Offered
13.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Elanco
13.2.1 Elanco Company Information
13.2.2 Elanco Endoparasiticide Product Offered
13.2.3 Elanco Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Elanco Main Business Overview
13.2.5 Elanco Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Endoparasiticide Product Offered
13.3.3 Zoetis Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Endoparasiticide Product Offered
13.4.3 Merck Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Endoparasiticide Product Offered
13.5.3 Virbac Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Novartis AG
13.6.1 Novartis AG Company Information
13.6.2 Novartis AG Endoparasiticide Product Offered
13.6.3 Novartis AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis AG Main Business Overview
13.6.5 Novartis AG Latest Developments
13.7 Ceva Sante Animlae
13.7.1 Ceva Sante Animlae Company Information
13.7.2 Ceva Sante Animlae Endoparasiticide Product Offered
13.7.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Ceva Sante Animlae Main Business Overview
13.7.5 Ceva Sante Animlae Latest Developments
13.8 Bayer AG
13.8.1 Bayer AG Company Information
13.8.2 Bayer AG Endoparasiticide Product Offered
13.8.3 Bayer AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bayer AG Main Business Overview
13.8.5 Bayer AG Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Endoparasiticide Product Offered
13.9.3 Eli Lilly Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Vetoquinol
13.10.1 Vetoquinol Company Information
13.10.2 Vetoquinol Endoparasiticide Product Offered
13.10.3 Vetoquinol Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Vetoquinol Main Business Overview
13.10.5 Vetoquinol Latest Developments
14 Research Findings and Conclusion
Table 1. Endoparasiticide Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Endoparasiticide Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Ear Tags
Table 4. Major Players of Tablets
Table 5. Major Players of Injectables
Table 6. Major Players of Feed Additives
Table 7. Global Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 8. Global Endoparasiticide Sales Market Share by Type (2017-2022)
Table 9. Global Endoparasiticide Revenue by Type (2017-2022) & ($ million)
Table 10. Global Endoparasiticide Revenue Market Share by Type (2017-2022)
Table 11. Global Endoparasiticide Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 13. Global Endoparasiticide Sales Market Share by Application (2017-2022)
Table 14. Global Endoparasiticide Revenue by Application (2017-2022)
Table 15. Global Endoparasiticide Revenue Market Share by Application (2017-2022)
Table 16. Global Endoparasiticide Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Endoparasiticide Sales by Company (2020-2022) & (K Units)
Table 18. Global Endoparasiticide Sales Market Share by Company (2020-2022)
Table 19. Global Endoparasiticide Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Endoparasiticide Revenue Market Share by Company (2020-2022)
Table 21. Global Endoparasiticide Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Endoparasiticide Producing Area Distribution and Sales Area
Table 23. Players Endoparasiticide Products Offered
Table 24. Endoparasiticide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Endoparasiticide Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Endoparasiticide Sales Market Share Geographic Region (2017-2022)
Table 29. Global Endoparasiticide Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Endoparasiticide Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Endoparasiticide Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Endoparasiticide Sales Market Share by Country/Region (2017-2022)
Table 33. Global Endoparasiticide Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Endoparasiticide Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Endoparasiticide Sales by Country (2017-2022) & (K Units)
Table 36. Americas Endoparasiticide Sales Market Share by Country (2017-2022)
Table 37. Americas Endoparasiticide Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Endoparasiticide Revenue Market Share by Country (2017-2022)
Table 39. Americas Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 40. Americas Endoparasiticide Sales Market Share by Type (2017-2022)
Table 41. Americas Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 42. Americas Endoparasiticide Sales Market Share by Application (2017-2022)
Table 43. APAC Endoparasiticide Sales by Region (2017-2022) & (K Units)
Table 44. APAC Endoparasiticide Sales Market Share by Region (2017-2022)
Table 45. APAC Endoparasiticide Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Endoparasiticide Revenue Market Share by Region (2017-2022)
Table 47. APAC Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 48. APAC Endoparasiticide Sales Market Share by Type (2017-2022)
Table 49. APAC Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 50. APAC Endoparasiticide Sales Market Share by Application (2017-2022)
Table 51. Europe Endoparasiticide Sales by Country (2017-2022) & (K Units)
Table 52. Europe Endoparasiticide Sales Market Share by Country (2017-2022)
Table 53. Europe Endoparasiticide Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Endoparasiticide Revenue Market Share by Country (2017-2022)
Table 55. Europe Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 56. Europe Endoparasiticide Sales Market Share by Type (2017-2022)
Table 57. Europe Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 58. Europe Endoparasiticide Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Endoparasiticide Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Endoparasiticide Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Endoparasiticide Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Endoparasiticide Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Endoparasiticide Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Endoparasiticide Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Endoparasiticide
Table 68. Key Market Challenges & Risks of Endoparasiticide
Table 69. Key Industry Trends of Endoparasiticide
Table 70. Endoparasiticide Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Endoparasiticide Distributors List
Table 73. Endoparasiticide Customer List
Table 74. Global Endoparasiticide Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Endoparasiticide Sales Market Forecast by Region
Table 76. Global Endoparasiticide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Endoparasiticide Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Endoparasiticide Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Endoparasiticide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Endoparasiticide Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Endoparasiticide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Endoparasiticide Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Endoparasiticide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Endoparasiticide Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Endoparasiticide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Endoparasiticide Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Endoparasiticide Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Endoparasiticide Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Endoparasiticide Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Endoparasiticide Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Endoparasiticide Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Endoparasiticide Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Endoparasiticide Revenue Market Share Forecast by Application (2023-2028)
Table 94. Boehringer Ingelheim Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 95. Boehringer Ingelheim Endoparasiticide Product Offered
Table 96. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Boehringer Ingelheim Main Business
Table 98. Boehringer Ingelheim Latest Developments
Table 99. Elanco Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 100. Elanco Endoparasiticide Product Offered
Table 101. Elanco Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Elanco Main Business
Table 103. Elanco Latest Developments
Table 104. Zoetis Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 105. Zoetis Endoparasiticide Product Offered
Table 106. Zoetis Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Zoetis Main Business
Table 108. Zoetis Latest Developments
Table 109. Merck Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 110. Merck Endoparasiticide Product Offered
Table 111. Merck Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Merck Main Business
Table 113. Merck Latest Developments
Table 114. Virbac Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 115. Virbac Endoparasiticide Product Offered
Table 116. Virbac Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Virbac Main Business
Table 118. Virbac Latest Developments
Table 119. Novartis AG Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis AG Endoparasiticide Product Offered
Table 121. Novartis AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Novartis AG Main Business
Table 123. Novartis AG Latest Developments
Table 124. Ceva Sante Animlae Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 125. Ceva Sante Animlae Endoparasiticide Product Offered
Table 126. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Ceva Sante Animlae Main Business
Table 128. Ceva Sante Animlae Latest Developments
Table 129. Bayer AG Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 130. Bayer AG Endoparasiticide Product Offered
Table 131. Bayer AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Bayer AG Main Business
Table 133. Bayer AG Latest Developments
Table 134. Eli Lilly Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 135. Eli Lilly Endoparasiticide Product Offered
Table 136. Eli Lilly Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Eli Lilly Main Business
Table 138. Eli Lilly Latest Developments
Table 139. Vetoquinol Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 140. Vetoquinol Endoparasiticide Product Offered
Table 141. Vetoquinol Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Vetoquinol Main Business
Table 143. Vetoquinol Latest Developments
List of Figures
Figure 1. Picture of Endoparasiticide
Figure 2. Endoparasiticide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Endoparasiticide Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Endoparasiticide Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Endoparasiticide Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Ear Tags
Figure 10. Product Picture of Tablets
Figure 11. Product Picture of Injectables
Figure 12. Product Picture of Feed Additives
Figure 13. Global Endoparasiticide Sales Market Share by Type in 2021
Figure 14. Global Endoparasiticide Revenue Market Share by Type (2017-2022)
Figure 15. Endoparasiticide Consumed in Veterinary Hospitals or Clinics
Figure 16. Global Endoparasiticide Market: Veterinary Hospitals or Clinics (2017-2022) & (K Units)
Figure 17. Endoparasiticide Consumed in Animal Farms
Figure 18. Global Endoparasiticide Market: Animal Farms (2017-2022) & (K Units)
Figure 19. Endoparasiticide Consumed in Home Care Settings
Figure 20. Global Endoparasiticide Market: Home Care Settings (2017-2022) & (K Units)
Figure 21. Global Endoparasiticide Sales Market Share by Application (2017-2022)
Figure 22. Global Endoparasiticide Revenue Market Share by Application in 2021
Figure 23. Endoparasiticide Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Endoparasiticide Revenue Market Share by Company in 2021
Figure 25. Global Endoparasiticide Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Endoparasiticide Revenue Market Share by Geographic Region in 2021
Figure 27. Global Endoparasiticide Sales Market Share by Region (2017-2022)
Figure 28. Global Endoparasiticide Revenue Market Share by Country/Region in 2021
Figure 29. Americas Endoparasiticide Sales 2017-2022 (K Units)
Figure 30. Americas Endoparasiticide Revenue 2017-2022 ($ Millions)
Figure 31. APAC Endoparasiticide Sales 2017-2022 (K Units)
Figure 32. APAC Endoparasiticide Revenue 2017-2022 ($ Millions)
Figure 33. Europe Endoparasiticide Sales 2017-2022 (K Units)
Figure 34. Europe Endoparasiticide Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Endoparasiticide Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Endoparasiticide Revenue 2017-2022 ($ Millions)
Figure 37. Americas Endoparasiticide Sales Market Share by Country in 2021
Figure 38. Americas Endoparasiticide Revenue Market Share by Country in 2021
Figure 39. United States Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Endoparasiticide Sales Market Share by Region in 2021
Figure 44. APAC Endoparasiticide Revenue Market Share by Regions in 2021
Figure 45. China Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Endoparasiticide Sales Market Share by Country in 2021
Figure 52. Europe Endoparasiticide Revenue Market Share by Country in 2021
Figure 53. Germany Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Endoparasiticide Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Endoparasiticide Revenue Market Share by Country in 2021
Figure 60. Egypt Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Endoparasiticide Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Endoparasiticide in 2021
Figure 66. Manufacturing Process Analysis of Endoparasiticide
Figure 67. Industry Chain Structure of Endoparasiticide
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...